Senior insider sale
President & CEO at MERSANA THERAPEUTICS, INC. — senior position signals high conviction
$88.8K
29.40K shares
What this filing means
PROTOPAPAS ANNA plans to sell 29.40K shares of MERSANA THERAPEUTICS, INC. valued at approximately $88.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/16/2024ACC: 0001104659-24-004207
DirectorOfficer· President & CEO
Since Jan 2019
29.40K
Shares to sell
$88.8K
Approx. market value
86.96K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Vesting of restricted stock unit grants
Services rendered
1/15/2024
38.96KVesting of restricted stock unit grant
Services rendered
1/14/2024
16.75KVesting of restricted stock unit grant
Services rendered
1/13/2024
31.25KTotal acquired86.96K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/15/2024 | Vesting of restricted stock unit grants Services rendered | 38.96K | — |
1/14/2024 | Vesting of restricted stock unit grant Services rendered | 16.75K | — |
1/13/2024 | Vesting of restricted stock unit grant Services rendered | 31.25K | — |
| Total | 86.96K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
29.40K
Market value
$88.8K
1/16/2024
Total
Units
29.40K
Value
$88.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/16/2024 | 29.40K | $88.8K | NASDAQ | Planned |
| Total | 29.40K | $88.8K | ||